Cargando…
Effects of dasatinib on CD8(+)T, Th1, and Treg cells in patients with chronic myeloid leukemia
OBJECTIVE: To investigate the immunomodulatory effects of the tyrosine kinase inhibitor (TKI) dasatinib on T-cell subtypes in patients with chronic myeloid leukemia (CML). METHODS: T helper (Th) 1, Th2, regulatory T (Treg), and CD8(+)T cell levels were detected in patients with CML (n = 9) before an...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607186/ https://www.ncbi.nlm.nih.gov/pubmed/31578901 http://dx.doi.org/10.1177/0300060519877321 |